Evidence map›Paper›PMID 24009000›Full record

ArticleGenetics in medicine : official journal of the American College of Medical Genetics2013

Electronic health record design and implementation for pharmacogenomics: a local perspective.

Josh F Peterson, Erica Bowton, Julie R Field, Marc Beller, Jennifer Mitchell, Jonathan Schildcrout, William Gregg, Kevin Johnson, Jim N Jirjis, Dan M Roden and 2 more

Registry-linked trialAbstract read
In one paragraph

Article in Genetics in medicine : official journal of the American College of Medical Genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05277116 (The Electronic Medical Records and GEnomics), which is not on this map. Cited by 62 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05277116 naactive not recruitingnot on this mapstarted 2022, after this paper: background citation

The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment

TypeinterventionalSponsorVanderbilt University Medical CenterRan2022 to 2030Enrolled26,877ConditionsGenetic DiseaseArmsGenome Informed Risk Assessment (GIRA) report
3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Frontiers in pharmacology · 2025
    Pooled it
  2. Genetically guided precision medicine clinical decision support tools: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2024
    Pooled it
  3. Review
  4. Actionable medications in Australian Vietnam War veterans: Implications for pre-emptive pharmacogenetic testing.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. The Implementation Chasm Hindering Genome-informed Health Care.The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2020
    Article
  17. Article
  18. Integrating pharmacogenomics into the electronic health record by implementing genomic indicators.Journal of the American Medical Informatics Association : JAMIA · 2020
    Article
  19. Article
  20. Precision Pharmacotherapy: Integrating Pharmacogenomics into Clinical Pharmacy Practice.Journal of the American College of Clinical Pharmacy : JACCP · 2019
    Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Josh F Peterson1] Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee, USA; [2] Division of General Internal Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA;
Erica Bowton
Julie R Field
Marc Beller
Jennifer Mitchell
Jonathan Schildcrout
William Gregg
Kevin Johnson
Jim N Jirjis
Dan M Roden
Jill M Pulley
Josh C Denny

Funding

VANDERBILT UNIVERSITY CTSA FOR PEDIATRIC RESEARCHUL1RR024975 · NCRR · VANDERBILT UNIVERSITY · PI BERNARD, GORDON RAPHAEL · 2007 to 2011
$45.7M
Pharmacogenomics of Arrhythmia TherapyU19HL065962 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RODEN, DAN M · 2010 to 2014
$17.4M
Pharmacogenomics of Anti-platlet Intervention-2 (PAPI-2) StudyU01HL105198 · NHLBI · UNIVERSITY OF MARYLAND BALTIMORE · PI SHULDINER, ALAN R. · 2010 to 2014
$13.6M
Vanderbilt Genome Electronic Records ProjectU01HG006378 · NHGRI · VANDERBILT UNIVERSITY · PI RODEN, DAN M · 2011 to 2014
$4.0M
PHARMACOGENOMIC RESOURCE FOR ENHANCED DECISIONS IN CLOPIDOGREL TREATMENT (PREDICTU47CI000824 · CI · VANDERBILT UNIVERSITY · PI LAPOSATA, MICHAEL · 2011 to 2012
$998k
NCPDCID CDC HHS U47 CI000824NCPDCID CDC HHS U47CI000824NCRR NIH HHS UL1 RR024975NHGRI NIH HHS U01 HG006378NHGRI NIH HHS U01HG006378NHLBI NIH HHS U01 HL105198NHLBI NIH HHS U01HL105198NHLBI NIH HHS U19 HL065962NHLBI NIH HHS U19HL065962
6 · The paper itself

Abstract

purposeThe design of electronic health records to translate genomic medicine into clinical care is crucial to successful introduction of new genomic services, yet there are few published guides to implementation.

methodsThe design, implemented features, and evolution of a locally developed electronic health record that supports a large pharmacogenomics program at a tertiary-care academic medical center was tracked over a 4-year development period.

resultsDevelopers and program staff created electronic health record mechanisms for ordering a pharmacogenomics panel in advance of clinical need (preemptive genotyping) and in response to a specific drug indication. Genetic data from panel-based genotyping were sequestered from the electronic health record until drug-gene interactions met evidentiary standards and deemed clinically actionable. A service to translate genotype to predicted drug-response phenotype populated a summary of drug-gene interactions, triggered inpatient and outpatient clinical decision support, updated laboratory records, and created gene results within online personal health records.

conclusionThe design of a locally developed electronic health record supporting pharmacogenomics has generalizable utility. The challenge of representing genomic data in a comprehensible and clinically actionable format is discussed along with reflection on the scalability of the model to larger sets of genomic data.

Indexed as

Electronic Health RecordsPharmacogeneticsAcademic Medical CentersDecision Support Systems, ClinicalGenotypeHealth Plan ImplementationHumansPhenotypeTranslational Research, Biomedical

Identifiers

PMID24009000
PMCPMC3925979

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.